Finelli A, Ismaila N, Bro B, Durack J, Eggener S, Evans A, et al. Management of small renal masses: american society of clinical oncology clinical practice guideline. J Clin Oncol. 2017;35:668–80. https://doi.org/10.1200/JCO.2016.69.9645.
Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, Capitanio U, Dabestani S, et al. European association of urology guidelines on renal cell carcinoma: the 2022 update. Eur Urol. 2022;82:399–410. https://doi.org/10.1016/j.eururo.2022.03.006.
Escudier B, Porta C, Schmidinger M, Rioux-Leclercq N, Bex A, Khoo V, et al. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30:706–20. https://doi.org/10.1093/annonc/mdz056.
Article CAS PubMed Google Scholar
Motzer RJ, Jonasch E, Agarwal N, Alva A, Baine M, Beckermann K, et al. Kidney cancer, version 3.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20:71–90. https://doi.org/10.6004/jnccn.2022.0001.
Article CAS PubMed PubMed Central Google Scholar
Campbell SC, Clark PE, Chang SS, Karam JA, Souter L, Uzzo RG. Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part I. J Urol. 2021;206:199–208. https://doi.org/10.1097/JU.0000000000001911.
Park BK, Shen SH, Fujimori M, Wang Y. Asian conference on tumor ablation guidelines for renal cell carcinoma. Investig Clin Urol. 2021;62:378–88. https://doi.org/10.4111/icu.20210168.
Article PubMed PubMed Central Google Scholar
Bertolotti L, Bazzocchi MV, Iemma E, Pagnini F, Ziglioli F, Maestroni U, et al. Radiofrequency ablation, cryoablation, and microwave ablation for the treatment of small renal masses: efficacy and complications. Diagnostics (Basel). 2023;13:388. https://doi.org/10.3390/diagnostics13030388.
Mukkamala A, He C, Weizer AZ, Hafez KS, Miller DC, Montgomery JS, et al. Long-term renal functional outcomes of minimally invasive partial nephrectomy for renal cell carcinoma. Urol Oncol. 2014;32:1247–51. https://doi.org/10.1016/j.urolonc.2014.04.012.
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305. https://doi.org/10.1056/NEJMoa041031.
Article CAS PubMed Google Scholar
Park IC, Yoon SK, Kim DW. Risk factors for renal function Impairment following radiofrequency ablation of renal tumors. Taehan Yongsang Uihakhoe Chi. 2022;83:317–30. https://doi.org/10.3348/jksr.2021.0076.
Patel HD, Pierorazio PM, Johnson MH, Sharma R, Iyoha E, Allaf ME, et al. Renal functional outcomes after surgery, ablation, and active surveillance of localized renal tumors: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2017;12:1057–69. https://doi.org/10.2215/CJN.11941116.
Article PubMed PubMed Central Google Scholar
Campbell SC, Clark PE, Chang SS, Karam JA, Souter L, Uzzo RG. Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part II. J Urol. 2021;206:209–18. https://doi.org/10.1097/JU.0000000000001912.
• Umakoshi N, Iguchi T, Matsui Y, Tomita K, Uka M, Kawabata T, et al. Renal cryoablation combined with prior transcatheter arterial embolization in non-dialysis patients with stage 4 or 5 chronic kidney disease: a retrospective study. Jpn J Radiol. 2023;41:1007–14. https://doi.org/10.1007/s11604-023-01416-z. This article showed cryoablation combined with prior TAE for RCC in non-dialysis patients with stage 4 or 5 CKD was effective and safe with an acceptable impact on renal function.
Article CAS PubMed PubMed Central Google Scholar
Lin Y, Liang P, Yu XL, Yu J, Cheng ZG, Han ZY, Liu F. Percutaneous microwave ablation of renal cell carcinoma is safe in patients with renal dysfunction. Int J Hyperthermia. 2017;33:440–5. https://doi.org/10.1080/02656736.2016.1266699.
Article CAS PubMed Google Scholar
Woldu SL, Thoreson GR, Okhunov Z, Ghandour R, Rothberg MB, RoyChoudhury A, et al. Comparison of renal parenchymal volume preservation between partial nephrectomy, cryoablation, and radiofrequency ablation using 3D volume measurements. J Endourol. 2015;29:948–55. https://doi.org/10.1089/end.2014.0866.
Gunn AJ, Parikh NS, Bhatia S. Society of interventional radiology quality improvement standards on percutaneous ablation in renal cell carcinoma. J Vasc Interv Radiol. 2020;31:195–201.e3. https://doi.org/10.1016/j.jvir.2019.11.004.
Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. Radiographics. 2005;25:S69–83. https://doi.org/10.1148/rg.25si055501.
Xiaobing W, Wentao G, Guangxiang L, Fan Z, Weidong G, Hongqian G, Gutian Z. Comparison of radiofrequency ablation and partial nephrectomy for tumor in a solitary kidney. BMC Urol. 2017;17:79. https://doi.org/10.1186/s12894-017-0269-4.
Article PubMed PubMed Central Google Scholar
Raman JD, Jafri SM, Qi D. Kidney function outcomes following thermal ablation of small renal masses. World J Nephrol. 2016;5:283–7. https://doi.org/10.5527/wjn.v5.i3.283.
Article PubMed PubMed Central Google Scholar
Ryoo H, Kang M, Sung HH, Jeon HG, Jeong BC, Jeon SS, et al. A comparison of functional and oncologic outcomes between partial nephrectomy and radiofrequency ablation in patients with chronic kidney disease after propensity score matching. Diagnostics (Basel). 2022;12:2292. https://doi.org/10.3390/diagnostics12102292.
Lai WJ, Chung HJ, Chen CK, Shen SH, Chou HP, Chiou YY, et al. Percutaneous computed tomography-guided cryoablation for renal tumor: experience in 30 cases. J Chin Med Assoc. 2015;78:308–15. https://doi.org/10.1016/j.jcma.2014.12.006.
Mason RJ, Atwell TD, Lohse C, Bhindi B, Weisbrod A, Boorjian SA, et al. Renal functional outcomes in patients undergoing percutaneous cryoablation or partial nephrectomy for a solitary renal mass. BJU Int. 2017;120:544–9. https://doi.org/10.1111/bju.13917.
Gobara H, Nakatsuka A, Shimizu K, Yamanaka T, Matsui Y, Iguchi T, et al. Cryoablation of renal cell carcinoma for patients with stage 4 or 5 non-dialysis chronic kidney disease. Jpn J Radiol. 2019;37:481–6. https://doi.org/10.1007/s11604-019-00821-7.
Article CAS PubMed Google Scholar
Asayama Y, Nishie A, Ushijima Y, Okamoto D, Morita K, Takao S, et al. Usefulness of a pretreatment CT-based modified RENAL nephrometry score in predicting renal function after cryotherapy for T1a renal mass. Cardiovasc Intervent Radiol. 2019;42:1128–34. https://doi.org/10.1007/s00270-019-02238-1.
John JB, Anderson M, Dutton T, Stott M, Crundwell M, Llewelyn R, et al. Percutaneous microwave ablation of renal masses in a UK cohort. BJU Int. 2021;127:486–94. https://doi.org/10.1111/bju.15224.
Article CAS PubMed Google Scholar
Knudsen JS, Duus LA, Mussmann B, Graumann O. Percutaneous renal tumor cryoablation effect on renal function. J Endourol. 2023;37:1149–55. https://doi.org/10.1089/end.2021.0959.
Lum MA, Shah SB, Durack FC, Nikolovski I. Imaging of small renal masses before and after thermal ablation. Radiographics. 2019;39:2134–45. https://doi.org/10.1148/rg.2019190083.
Umakoshi N, Iguchi T, Hiraki T, Matsui Y, Tomita K, Uka M, et al. Correlation between renal ablation zone in contrast-enhanced CT and non-enhanced MRI during the early period following percutaneous cryoablation. Jpn J Radiol. 2022;40:1087–95. https://doi.org/10.1007/s11604-022-01285-y.
Article PubMed PubMed Central Google Scholar
Guo F, Hu B, Chen L, Li J. Clinical application of contrast-enhanced ultrasound after percutaneous renal tumor ablation. Br J Radiol. 2019;92:20190183. https://doi.org/10.1259/bjr.20190183.
Article PubMed PubMed Central Google Scholar
Zeccolini G, Del Biondo D, Cicero C, Casarin A, Guarise A, Celia A. Comparison of Contrast-Enhanced Ultrasound Scan (CEUS) and MRI in the follow-up of cryoablation for small renal tumors. Experience on 25 cases. Urologia. 2014;81 Suppl 23:S1–8. https://doi.org/10.5301/RU.2014.11986.
Tsivian M, Rampersaud EN Jr, del Pilar Laguna Pes M, Joniau S, Leveillee RJ, Shingleton WB, et al. Small renal mass biopsy-how, what and when: report from an international consensus panel. BJU Int. 2014;113:854–63. https://doi.org/10.1111/bju.12470.
Domi R, Huti G, Sula H, Baftiu N, Kaci M, Bodeci A, Pesha A. From pre-existing renal failure to perioperative renal protection: the anesthesiologist’s dilemmas. Anesth Pain Med. 2016;6:e32386. https://doi.org/10.5812/aapm.32386.
Article PubMed PubMed Central Google Scholar
Truesdale CM, Soulen MC, Clark TW, Mondschein JI, Wehrenberg-Klee E, Malkowicz SB, et al. Percutaneous computed tomography-guided renal mass radiofrequency ablation versus cryoablation: doses of sedation medication used. J Vasc Interv Radiol. 2013;24:347–50. https://doi.org/10.1016/j.jvir.2012.11.022.
De Marini P, Cazzato RL, Garnon J, Dalili D, Leonard-Lorant I, Leclerc L, et al. Safety and oncologic efficacy of percutaneous MRI-guided cryoablation of intraparenchymal renal cancers. Diagn Interv Imaging. 2021;102:531–8. https://doi.org/10.1016/j.diii.2021.04.002.
Comments (0)